CliffBio
small molecule

MANGANESE CHLORIDE

MANGANESE CHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyFresenius Kabi →See this company's full patent-cliff portfolio

Drug detail

Brand nameMANGANESE CHLORIDE
Active ingredientMANGANESE CHLORIDE
StrengthEQ 0.1MG MANGANESE/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalJuly 2025
Marketing statusRX

More from Fresenius Kabi

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.